IVD Excellence: Reliable Tumor Antibodies for Accurate Results

Experience the reliability of our tumor markers. You can read more details about each marker to understand the whole portfolio we are offering. Discover how our high-quality tumor antibodies can help you develop more accurate and reliable diagnostic tests.

Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. The use of tumor biomarkers plays a crucial role in screening, diagnosis, and management of cancers, significantly contributing to the reduction in cancer mortality and improving life expectancy.

Alpha-fetoprotein (AFP) antibodies (Cat. #4F16): Alpha-fetoprotein (AFP) is used as a tumor marker for hepatocellular carcinoma (HCC) in combination with ultrasound and other imaging modalities. AFP levels reflect tumor size and correlate with disease progression, making them a valuable indicator for monitoring treatment effects and prognosis.

CA-125 antibodies (Cat. # 4C29): routinely used in screening for ovarian cancer (and other related cancers)

CA72-4 antibodies (Cat. #4CA72): assists in the diagnosis of gastrointestinal and ovarian cancers and therapeutic monitoring.

Carcinoembryonic antigen (CEA) antibodies (Cat. # 4CA30/4CA30cc): indicates certain types of cancers and monitors treatment.

CYFRA21-1 antibodies (Cat.# 4CY1): assists in differential diagnosis, monitoring, and prognosis of lung cancer.

Human papilloma virus (HPV), type 16, oncoprotein E7 antibodies ( Cat. # 3HP16): monitors HPV infections related to cancer.

Human papilloma virus (HPV), type 18, oncoprotein E7 antibodies (Cat. # 3HP18): monitors HPV infections related to cancer.

Prostate-specific antigen (PSA) antibodies (Cat. # 4P33): assists in screening for prostate cancer and monitoring treatment.


Other tumor biomarkers

Human chorionic gonadotropin (HCG) antibodies (Cat. # 2H8): used to diagnose, monitor treatment, and detect recurrence of testicular cancer.

Lambda (free) light chains antibodies (Cat. # 1L7cc) and Kappa light chains antibodies (Cat. # 1K5cc): biomarkers for indicating the multiple myeloma and amyloidosis.

S100 proteins, human antibodies (Cat. # 4S37): helps characterize malignant melanoma and some other tumors and provides prognostic values.

Thyroglobulin antibodies (Cat. # 2TG12cc): monitors the treatment of patients with differentiated thyroid cancer (DTC).